Literature DB >> 6792243

Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis.

S H Siddiqi, A Aziz, Z Reggiardo, G Middlebrook.   

Abstract

Drug susceptibility studies on strains of Mycobacterium tuberculosis isolated from widely different populations of patients and tested by two different techniques indicated that all 55 strains resistant to rifampicin were also resistant to isoniazid, while many strains resistant to isoniazid were found to be susceptible to rifampicin. This observation, which has as yet unknown laboratory and clinical significance, may be particularly useful in management of patients. Further studies are called for to establish this relation.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6792243      PMCID： PMC493987          DOI： 10.1136/jcp.34.8.927

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  10 in total

Review 1.  Rifampin: a semisynthetic derivative of rifamycin--a prototype for the future.

Authors:  W Lester
Journal:  Annu Rev Microbiol       Date:  1972       Impact factor: 15.500

2.  The antimycobacterial activity of rifampin.

Authors:  G L Hobby; T F Lenert
Journal:  Am Rev Respir Dis       Date:  1968-04

3.  Some comparative aspects of rifampicin and isoniazid.

Authors:  G Canetti; M Le Lirzin; G Porven; N Rist; F Grumbach
Journal:  Tubercle       Date:  1968-12

4.  Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.

Authors:  L Verbist; A Gyselen
Journal:  Am Rev Respir Dis       Date:  1968-12

5.  In vitro activity of rifampin against the H37RV strain of Mycobacterium tuberculosis.

Authors:  G L Hobby; T F Lenert; J Maier-Engallena
Journal:  Am Rev Respir Dis       Date:  1969-03

6.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

Authors:  G Canetti; W Fox; A Khomenko; H T Mahler; N K Menon; D A Mitchison; N Rist; N A Smelev
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

7.  [Virulence of rifampicin-resistant tubercle bacilli for experimental animals (preliminary report)].

Authors:  T Osato; H Shimizu
Journal:  Kekkaku       Date:  1972-05

8.  The pattern of resistance development to rifampicin in Mycobacterium tuberculosis.

Authors:  M Tsukamura
Journal:  Tubercle       Date:  1972-06

9.  Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media.

Authors:  G Middlebrook; Z Reggiardo; W D Tigertt
Journal:  Am Rev Respir Dis       Date:  1977-06

10.  Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol.

Authors:  J M Dickinson; D A Mitchison
Journal:  Tubercle       Date:  1976-12
  10 in total
  3 in total

1.  Low incidence of rifampicin-resistant tubercle bacilli.

Authors:  C H Collins; M D Yates
Journal:  Thorax       Date:  1982-07       Impact factor: 9.139

2.  Genetic Mimetics of Mycobacterium tuberculosis and Methicillin-Resistant Staphylococcus aureus as Verification Standards for Molecular Diagnostics.

Authors:  Edith Erika Machowski; Bavesh Davandra Kana
Journal:  J Clin Microbiol       Date:  2017-09-20       Impact factor: 5.948

3.  Susceptibility testing of filamentous fungi to amphotericin B by a rapid radiometric method.

Authors:  W G Merz; D Fay; B Thumar; D Dixon
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.